Victor Forge
Muscle promoters are a key component of gene therapy, a strategy to cure rare diseases. They are regulatory sequences that drive high expression of a therapeutic transgene in skeletal, cardiac, and smooth muscles. Muscle promoters are designed to be short and compact, with tissue-specific expression, to ensure limited side effects. The muscle hybrid (MH) promoter is a novel promoter that has shown potential for gene therapy in muscle cells, providing stable transgene expression and high levels of therapeutic proteins. Muscle-specific promoters are being developed based on skeletal muscle α-actin, muscle creatine kinase, and desmin genes, as well as other genes expressed in muscles.
| Characteristics | Values |
|---|---|
| Definition | Muscle promoters are synthetic or natural promoters used in gene therapy to drive high and robust expression of a therapeutic transgene in skeletal muscles, the diaphragm, and the heart, while exhibiting limited activity in non-target tissues. |
| Use | Muscle promoters are used in gene therapy to treat rare diseases, specifically muscle-related genetic disorders. |
| Benefits of muscle as target for gene therapy | Muscles are a convenient target for gene therapy due to the long lifespan of muscle fibers, easy access for intramuscular injections, and high protein synthesis capacity. |
| Drawbacks of muscle as target for gene therapy | Muscles make up 30-40% of body weight, requiring high doses of gene therapy drugs. Muscle tissue is also structurally heterogeneous, making it difficult to develop equally effective treatments for different types of muscle tissues. |
| Types of muscle promoters | Synthetic promoters, natural promoters |
| Examples of synthetic promoters | Muscle Hybrid (MH) promoter, muscle-enriched TEF-1 isoforms, muscle-specific enhancer and promoter chimeras, muscle-specific reverse tetracycline transactivator (rtTA) |
| Examples of natural promoters | Muscle creatine kinase (MCK) promoter, muscle-specific α-actin promoter, muscle-specific desmin promoter, muscle-specific troponin T/I promoter |
Explore related products
$21.99
What You'll Learn
Muscle-specific promoters for gene therapy
Muscle-specific promoters are an important tool in gene therapy, which is a promising strategy to cure rare diseases. Gene therapy is a state-of-the-art approach to treating muscular disorders, which are caused by a protein deficiency resulting from mutations in the corresponding gene. The functional copy of a gene is delivered to the affected tissues using viral vectors.
Muscle tissue is an important target for gene therapy because of the wide range of muscle-related genetic disorders that can potentially be treated with gene replacement or correction. Muscle tissue is also an optimal platform for the production of secretory proteins such as clotting factors, hormones, and specific enzymes. Clinical trials have proven that muscle tissue-focused gene therapy procedures can be safe.
One challenge in gene therapy is the lack of regulatory sequences ensuring specific and robust expression in skeletal and cardiac muscle. This is a substantial limitation of gene therapy efficiency when targeting muscle tissue. To address this issue, researchers have developed a novel muscle hybrid (MH) promoter that is highly active in both skeletal and cardiac muscle cells. The MH promoter has an easily exchangeable modular structure, including an intronic module that enhances the expression of the gene driven by it. When combined with AAV2/9, the MH promoter provides high in vivo expression levels in skeletal muscle and the heart after both intramuscular and systemic delivery.
Another challenge in gene therapy is the need for high doses of the gene therapy drug due to the high proportion of body weight that muscles make up (30-40%) [13]. This complicates the development of gene therapy drugs that would be equally effective in different types of muscle tissues. To address this issue, researchers have developed compact, muscle-specific promoters for adeno-associated viral (AAV) vectors, which are widely used for gene transfer in vivo. These compact promoters, such as the dMCK and tMCK promoters, are highly active and tissue-specific, making them well-suited for AAV vectors in muscle-directed gene therapy studies.
Kolavhes: Muscle Friend or Foe?
You may want to see also
Explore related products
Muscle hybrid promoters
One of the limitations of gene therapy efficiency in muscle tissue is the lack of regulatory sequences that ensure specific and robust expression in skeletal and cardiac muscle. Muscle hybrid promoters address this issue by providing a highly active, muscle-specific promoter for efficient gene expression. The MH promoter has an easily exchangeable modular structure, including an intronic module that enhances the expression of the gene it drives.
The MH promoter has been shown to be highly active in both skeletal and cardiac muscle cells, with higher activity and protein levels than standard promoters such as CMV and desmin gene promoters. It provides stable transgene expression, ensuring high levels of therapeutic proteins and limited side effects due to its specificity. This makes it a more efficient promoter than the desmin-encoding gene promoter while maintaining the same specificity.
The MH promoter is designed to fit into a wide variety of vectors and strategies useful for gene therapy. When combined with AAV2/9 delivery, the MH promoter-driven expression ensures a specific and high level of expression in skeletal muscle and the heart in vivo. This makes it a versatile tool for gene therapy, with potential applications in various vectors and strategies.
In conclusion, muscle hybrid promoters offer a promising approach to enhancing the efficiency and specificity of gene therapy for muscle-based disorders. By providing stable and high-level expression in skeletal and cardiac muscles, the MH promoter improves upon the limitations of previously used promoters and has the potential to revolutionize the treatment of rare diseases and muscle-related genetic disorders.
Triggering Muscle Failure: Techniques for Maximum Muscle Growth
You may want to see also
Explore related products
Muscle-specific gene replacement therapy
Muscle tissue is an important target for gene replacement therapy due to the prevalence of muscle-related genetic disorders, which affect 20-25 per 100,000 births per year. Additionally, muscle tissue is an optimal platform for the production of secretory proteins such as clotting factors, hormones, and specific enzymes. Clinical trials have proven the safety of muscle tissue-focused gene therapy procedures.
One challenge in muscle-specific gene replacement therapy is the need for high doses of the gene therapy drug due to the substantial volume of muscle tissue, which comprises roughly 30-40% of body weight. This requires the development of promoters that confer long-term sustained high expression in muscles affected by the disease while exhibiting limited activity in other tissues. Promoters are regulatory elements that control gene transcription and play a crucial role in the success of gene therapy.
Efforts have been made to develop highly compact, active, and tissue-specific promoters for use in adeno-associated viral (AAV) vectors, which are commonly used for gene transfer in vivo. For example, the muscle creatine kinase (MCK) promoter has been abbreviated to create shorter and stronger promoters, such as dMCK and tMCK. These promoters exhibit high activity in skeletal muscles but are inactive in non-muscle cell lines and the mouse liver.
Another approach to muscle-specific gene replacement therapy involves the use of muscle-derived stem cells and growth factors to promote muscle regeneration and healing. Non-viral methods, such as the transfer of TGF-beta1, have been explored to promote the differentiation of muscle-derived stem cells and address muscle fibrosis. Additionally, the combination of stem cells and gene therapy has shown potential in pre-clinical studies for treating muscular dystrophies.
Keto for Muscle Gain: Is It Effective?
You may want to see also
Explore related products
![eFlow Nutrition Turkesterone Supplement for Men [Highest Purity] + Cyclodextrin for High Absorption - Increase Stamina, Lean Muscle Growth & Recovery, Boosts Drive - 3rd Party Tested (60 Capsules)](https://m.media-amazon.com/images/I/61LB+u8bFnL._AC_UL320_.jpg)
Muscle promoter expression
The success of gene therapy depends on achieving high transgene expression levels in the target tissues. Muscle-specific promoters are designed to drive robust expression in skeletal muscles, the diaphragm, and the heart while remaining inactive in non-target tissues. This specificity is crucial to avoiding side effects and reducing the immune response to therapy. Strong and constitutive promoters, such as respiratory syncytial virus (RSV), cytomegalovirus (CMV), and elongation factor 1a (EF1a), can achieve high expression levels, but they may also trigger an immune response if expressed in non-target tissues.
To overcome these challenges, researchers have developed compact, muscle-specific promoters for use in adeno-associated viral (AAV) vectors. The muscle creatine kinase (MCK) promoter, for example, has been abbreviated to create shorter promoters like dMCK and tMCK that are highly active in skeletal muscles. Other compact muscle-specific promoters, such as the synthetic promoter SP-301, have also shown promising results in transgenic mice, accelerating translocation and increasing the level of plasmid in the nuclei of myoblast cells.
Additionally, a novel muscle hybrid (MH) promoter has been described, which is highly active in both skeletal and cardiac muscle cells. This MH promoter has an easily exchangeable modular structure, including an intronic module that enhances gene expression. When combined with AAV2/9, the MH promoter provides high in vivo expression levels in skeletal muscle and the heart after intramuscular and systemic delivery.
In summary, muscle promoter expression plays a critical role in gene therapy for muscular disorders. The development of compact, muscle-specific promoters has improved the efficiency and specificity of gene expression in skeletal and cardiac muscles, leading to more effective gene therapy treatments.
Jogging: Which Muscles Are Getting a Workout?
You may want to see also
Explore related products
Muscle promoter vectors
One key challenge in muscle-directed gene therapy is achieving efficient and specific expression of therapeutic molecules in the target muscles. To address this, muscle-specific promoters are designed to drive high and robust expression of therapeutic transgenes in the desired muscles while minimising activity in non-target tissues. This specificity is essential to reducing potential side effects and avoiding unwanted immune responses.
Adeno-associated viral (AAV) vectors have been widely utilised for gene transfer in vivo. However, AAVs pose constraints on the size of tissue-specific promoters that can be employed. Consequently, efforts are directed towards developing compact, yet potent and tissue-specific promoters compatible with AAV vectors.
The muscle creatine kinase (MCK) promoter has been extensively studied and modified to enhance its effectiveness. The dMCK and tMCK promoters, generated by combining the MCK enhancer with its basal promoter, exhibit improved strength and specificity compared to their predecessors. The tMCK promoter, in particular, surpasses the efficacy of the widely used cytomegalovirus (CMV) promoter.
Additionally, the chimeric promoter MHCK7, comprising a 206-bp enhancer and a proximal promoter with specific modifications, has been designed to achieve high transgene expression in cardiac muscle. The MHCK7 promoter has demonstrated comparable expression levels to CMV and RSV promoters in skeletal and cardiac muscles.
The modular muscle hybrid (MH) promoter is another innovative development, exhibiting high activity in skeletal and cardiac muscle cells while maintaining low activity in non-muscular cell types. When combined with AAV2/9 delivery, the MH promoter ensures specific and elevated expression in skeletal muscle and the heart in vivo.
Relieving Muscle Stimulation: Techniques for Instant Relaxation
You may want to see also
